{"id":127178,"name":"VERTEX PHARMACEUTICALS","slug":"vertex-pharmaceuticals","state":"MA","country":"United States of America","description":"Global biotechnology company.","totalSpending":2400000,"filings":33,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":240000},{"year":2020,"income":280000},{"year":2021,"income":320000},{"year":2022,"income":320000},{"year":2023,"income":320000},{"year":2024,"income":400000},{"year":2025,"income":280000}],"issues":["HCR","MMM","DEF"],"firms":["TIBER CREEK GROUP"],"lobbyists":["JONATHON JONES","SEAN RICHARDSON","ASHLI PALMER","COREY MALMGREN","LINDSEY LEDWIN","JOHN GONZALEZ","EMILY KIRLIN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Executive Office of the President (EOP)"],"sampleDescriptions":["Issues surrounding treatment of rare diseases. Issues related to price and transparency.","Issues surrounding treatment of rare diseases. Issues related to price and transparency.","Issues surrounding treatment of rare diseases. Issues related to price and transparency.","Issues surrounding treatment of rare diseases. Issues related to price and transparency.","Issues surrounding treatment of rare diseases. Issues related to price and transparency ."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}